Member Info for quercusrobor

https://www.investegate.co.uk/e-therapeutics-plc--etx-/rns/holding-s--in-company/202002201809546729D/
TR-1: S tandard form for notification of major holdings

https://www.independent.co.uk/news/science/ai-antibiotic-drug-resistant-disease-halicin-artificial-intelligence-a9348716.html

AI discovers antibiotic to treat drug-resistant diseases for first time

Researchers used computer model that can screen more than a hundred million chemical compounds in a matter of days

Jamie Harris
7 hours ago

from the other place....not exactly my choice of language(in print)...the sentiment cannot be faulted....:)The Stigologist19 Feb '20 - 22:50 - 146 of 147 0 2 0Utter ****Spends the last 30 days talking about **** like NMC, Angus, Primorius etcETX have some news and he thinks he's an expert on it********

Member Info for Supergirl
Posts
(Last 30 Days)
5
Posts
(All Time)
5
Last Post
19th Feb 2020
Member Since
19th Feb 2020
Share Chat Post Distribution over the last 30 days
Tertiary Minerals (TYM): 1Tertiary Minerals (TYM): 1Nuformix (NFX): 1Nuformix (NFX): 1Greatland (GGP): 1Greatland (GGP): 1Eurasia Mining (EUA): 1Eurasia Mining (EUA): 188 Energy (88E): 188 Energy (88E): 1

utterly pathetic

The February 2020 Pgm Market Report is available to download now.

This is Johnson Matthey's free market review of supply and demand for the platinum group metals.

http://www.platinum.matthey.com/documents/new-item/pgm%20market%20reports/pgm_market_report_february_2020.pdf

The February 2020 Pgm Market Report is available to download now.

This is Johnson Matthey's free market review of supply and demand for the platinum group metals.

http://www.platinum.matthey.com/documents/new-item/pgm%20market%20reports/pgm_market_report_february_2020.pdf

Feb 17 2020, 09:10 4.00 11,449,600 3.70 4.00 Buy £457,984.00000 O

edit..not for those who KNOW everything about everything.....

https://www.ihealthcareanalyst.com/global-idiopathic-pulmonary-fibrosis-treatment-market/
The global market for idiopathic pulmonary fibrosis expected to reach $5.9 billion by 2025, growing at CAGR 13.1% over the forecast period, driven by increasing drug prices and rapid approval of new treatments.

According to pulmonary fibrosis foundation, the non-pharmacologic management of pulmonary fibrosis (PF) to manage symptoms and prevent future complications includes home pulse oximetry, pulmonary rehabilitation, vaccination, weight management, and lung transplantation. In the United States; in 2013, PF accounted for nearly half of all lung transplants performed.
https://www.etherapeutics.co.uk/what-we-do/our-assets/
Idiopathic pulmonary fibrosis (“IPF”)

Fibrosis, the excessive accumulation of fibrous connective tissue and extracellular matrix components, such as collagen and fibronectin, in and around inflamed or damaged tissue, is the final pathological outcome of most chronic inflammatory diseases. Idiopathic pulmonary fibrosis ("IPF") is a chronic, progressive disease of unknown aetiology that causes lung scarring. The disease prognosis is poor, with a median survival of 3-5 years after diagnosis. Estimated prevalence is c.20 people per 100,000 worldwide. Thereapeutic options are limited and the large unmet medical need in the field remains. Through our NDD approach, the use of omic data and network biology analysis could help to discover new drugs. Read more about this programme on https://www.etherapeutics.co.uk/what-we-do/fibrosis/ or see the downloads section and the bottom of this page.

fwiw
disregarding,for the time being,the breakaway gap at c 4.6,...~I'm looking for a backtest to c 5.8-ish (tuesday high)...will be adding at that level.

re...takeover based on average shareprice over last 3 months would be a nightmare
exactly..
which from where I'm sitting makes it all the more extraordinary that there has not been any semblance of corporate pushback...BoD share buying etc...how can a t/o or opportunistic offer benefit those institutions who coughed 11p + Mr Fitzp etc ?

re.. take over tactics to drive the price down to as cheap as possible?

in whose best interest would it be to drive the price lower?

re...Same amount bought and sold but mm's bring down price every day

is the reason for this simply one of supply and demand?

re..... I thought each test was about £4.50.

£4.62 to be exact....(all of £152,460)

Thanks AJ for the comprehensive and reasoned reply.
Nothing there I would not agree with,however frustrating the current position may be.
Hold hard........

AJamesW ,samplemix1962 et al,
do you remain sanguine and phlegmatic to a degree, with regard to this very attritional experience,reassured by your confidence and knowledge of this business,that all will be well in the end?

re..As a long term holder I am in no way worried as to sell as I see the end game too big an opportunity to miss out on..

my thoughts exactly...this is a small,albeit irritating internal matter ,which has now been clinically removed.Points to Dan etc on balance for dealing with this effectively.We can all now move on.

re..how long will the management let this slide carry on before doing something to try and alleviate it
This has to be an extraordinarilly cackhanded performance from the Bod...who really should know better from their collective 'experience' how to handle this sort of situation.
I'm reliably informed by a colleague that the ever loyal Justin trotted out the line that..'they were aware of certain bad actors..(quote)..who had their own agendas' vis a vis the share price.Really???.It was suggested that the very tried and tested route of showing confidence in your own business,was....you've guessed it...a collective and significant purchase of your own equity by the Bod and other connected parties.This has singularly been left undone.All hugely unimpressive....its about time there was some pushback from the Bod and whoever is advising them.

re....Decent director buys would be received very well.
Indeed....

Yicai Global ????
@yicaichina
·
11h
China's daily output of coronavirus testing kits has reached 773,000 units, which is 40 times the number of suspected cases, hence meeting demand, Tian Yulong, chief engineer at the MIIT, said in a press briefing today. #WuhanPneumonia

..£4.62p per test